We are live on ! Find out more
ENZ

Enzo Biochem, Inc.

Delisted

ENZ was delisted on the 17th of April, 2025.

82 hedge funds and large institutions have $94.5M invested in Enzo Biochem, Inc. in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 33 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $73.8M → $94.5M (+$20.7M)

2% less funds holding

Funds holding: 8482 (-2)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

42% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 33

92% less call options, than puts

Call options by funds: $492K | Put options by funds: $6.23M

Holders
82
Holders Change
-2
Holders Change %
-2.38%
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
9
Increased
19
Reduced
33
Closed
11
Calls
$492K
Puts
$6.23M
Net Calls
-$5.74M
Net Calls Change
-$3.24M

ENZ Hedge Fund Activity: Q1 2021 in Review

82 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2021, worth a combined $94.5M — up 28% from $73.8M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ENZ and 9 opened new positions — a net loss of 2 holders — while 33 trimmed existing stakes and 19 added.

The largest buyer was BlackRock, adding an estimated $477K. The largest seller was Ariel Investments, cutting an estimated $1.97M.

  • 82 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2021, down from 84 in Q4 2020.
  • Funds reported $94.5M of Enzo Biochem, Inc. stock for Q1 2021, up 28% quarter-over-quarter.
  • 9 funds opened new Enzo Biochem, Inc. positions in Q1 2021 and 11 closed out, a net change of -2 holders.
  • The largest Enzo Biochem, Inc. buyer in Q1 2021 was BlackRock, an estimated $477K added.
  • The largest Enzo Biochem, Inc. seller in Q1 2021 was Ariel Investments, an estimated $1.97M sold.

Based on aggregated 13F filings for Q1 2021.